BridgeBio Pharma: Taking Some Profits (NASDAQ:BBIO) seekingalpha.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from seekingalpha.com Daily Mail and Mail on Sunday newspapers.
Galapagos has a new CEO since April 2022. The new strategy is taking shape with some research programs scrapped and small assets acquired. Read more here.
BridgeBio Pharma's stock fell at the end of 2021 on some disappointing trial results. Read whether late-stage candidates and collaboration deals make BBIO a Buy.
Genelux Corp. is seeking U.S. public capital market investment to fund further advancement of its pipeline. Click here to read more about GNLX's $30m IPO filing.